Weight-Loss Drug Demand Drives Rapid Sales Growth for Healthcare Tech Firm

New York, Friday, 13 November 2026.
DataMEDS AI achieved 50% revenue growth to reach $2.7 million in the third quarter of 2026, fueled by weight-loss drug prescriptions and expanding diagnostic services.